USPTO serial 79304754
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard S. Finkelstein
Richard S. Finkelstein RC Trademark Company, LLCP.O. Box 940Brookfield, CT 06804UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; Medical preparations for the treatment of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; pain relief medication; medicines for the treatment of sleep disturbance; medicines for the treatment of hypertension; medicines for the treatment of metabolic disorders | ACTIVE | — |
| 009 | Downloadable computer software for facilitating optimisation of drug dosage and patient instruction; downloadable communication software for providing access to the Internet; downloadable data processing software; Downloadable computer software for use as an application programming interface (API); Downloadable cloud-computing software for deploying virtual machines to a cloud computing platform, managing virtual machines on a cloud computing platform; Downloadable interface software for facilitating optimisation of drug dosage and patient instruction; Downloadable computer application software for mobile phones, namely, software for facilitating optimisation of drug dosage and patient instruction; Downloadable artificial intelligence software; humanoid robots with artificial intelligence; Downloadable cloud computing software; Computer storage devices, namely, high-speed storage subsystems for storage and backup of electronic data either locally or via a telecommunications network; Downloadable data management software; Downloadable data processing software; Downloadable artificial intelligence software for data analysis; downloadable artificial intelligence software for healthcare; downloadable machine learning software; computer hardware; data processing apparatus; monitoring apparatus, namely, Wireless controllers to monitor and control the functioning of other electronic devices; Downloadable software for monitoring vital functions; Downloadable diagnostic software for monitoring vital functions; wearable activity trackers | ACTIVE | — |
| 010 | Medical apparatus, namely blood pressure monitor, temperature sensors; Medical diagnostic apparatus for testing urine sulfatoxymelatonin levels, saliva cortisol levels; Apparatus, instruments and devices for measuring, monitoring and recording body vital health parameters, namely, body composition analyzers for medical purposes, heart rate monitors, blood pressure monitors, and pulse oximeters; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Electronic temperature monitors for medical use; Electronic monitors for medical use for blood pressure, heart rate, temperature sensors, oximetry measurement, sleep monitors, cough characteristic monitors; parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 042 | Scientific laboratory and technological consulting services in the field of healthcare, pharmaceuticals, drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; scientific research services; scientific research relating to medicine; scientific research relating to pharmaceuticals; research and development services relating to medicine; research and development services relating to pharmaceuticals; research and development services relating to drugs; research and development services relating to healthcare; providing medical research and scientific research information in the field of pharmaceuticals and medicine; provision of scientific information, development and testing of computer methods, algorithms and software; Software as a service (SAAS) services featuring software for healthcare, pharmaceutical drugs, drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; Platform as a service (PAAS) featuring computer software platforms for healthcare, pharmaceutical drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; providing information and data relating to scientific and technological research and development; design and development of software and hardware; updating and maintenance of computer software; information technology consulting services for the pharmaceutical and healthcare industries; creating of computer programs for medical applications | ACTIVE | — |
| 044 | Healthcare; health consultancy; healthcare services; healthcare information services; healthcare advisory services; health clinical services; health screening services in the field of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; medical health assessment services; medical therapy services; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; individual medical counseling services provided to patients; medical care and analysis services relating to patient treatment; health counselling; health screening; Medical diagnostic testing, monitoring and reporting services; providing news and information in the field of healthcare; Providing medical information to patients, medical professionals in the form of reports in the field of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; providing medical information; information and advisory related to all of the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 29, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 29, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 18, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 18, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 24, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 15, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 15, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 9, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |